• 1. Exclusive self-aligned β-phase PVDF films with abnormal piezoelectric coefficient prepared via phase inversion?
  N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260
• 2. Estimation of fusel-oil in spirits
  Analyst, 1890,15, 203-209
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Introduction to 4-(difluoromethoxy)-3-fluorobenzonitrile (CAS No. 954388-59-1)

4-(difluoromethoxy)-3-fluorobenzonitrile, identified by its Chemical Abstracts Service (CAS) number 954388-59-1, is a fluorinated aromatic nitrile that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to a class of molecules characterized by the presence of both fluorine and methoxy substituents, which are known to enhance biological activity and metabolic stability. The structural features of this molecule make it a valuable intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological and inflammatory disorders.

The fluorine atoms in 4-(difluoromethoxy)-3-fluorobenzonitrile play a crucial role in modulating the pharmacokinetic properties of drug candidates. Fluorine substitution is widely employed in medicinal chemistry to improve lipophilicity, reduce metabolic clearance, and enhance binding affinity to biological targets. In particular, the electron-withdrawing nature of fluorine can influence the electronic distribution of the aromatic ring, thereby affecting reactivity and interaction with enzymes or receptors. Recent studies have highlighted the importance of fluorinated benzonitriles in developing antiviral and anticancer agents, where the presence of multiple fluorine atoms can lead to increased potency and selectivity.

The methoxy group at the 4-position in 4-(difluoromethoxy)-3-fluorobenzonitrile further contributes to its pharmacological potential. Methoxy-substituted aromatic compounds are often found in natural products and synthetic drugs due to their ability to enhance solubility and bioavailability. Additionally, the methoxy group can participate in hydrogen bonding interactions, which is critical for receptor binding. In a notable study published in Journal of Medicinal Chemistry, researchers demonstrated that methoxy-fluoro benzonitriles exhibit promising activity against inflammatory pathways by modulating enzyme activity through hydrogen bonding with key residues.

Recent advancements in computational chemistry have enabled the rational design of 4-(difluoromethoxy)-3-fluorobenzonitrile derivatives with enhanced therapeutic profiles. Molecular docking simulations have been used to predict binding affinities with target proteins such as kinases and ion channels. For instance, a study published in Organic Letters reported that fluorinated benzonitriles can act as scaffolds for developing small-molecule inhibitors by optimizing steric and electronic properties through computational screening.

The synthesis of 4-(difluoromethoxy)-3-fluorobenzonitrile involves multi-step organic transformations, typically starting from commercially available precursors such as 3-fluoraniline. The introduction of fluorine atoms requires specialized reagents and conditions to ensure high yield and purity. Fluorination reactions, such as electrophilic aromatic substitution or metal-catalyzed cross-coupling, are commonly employed. The subsequent methylation at the 4-position is achieved using methylating agents like dimethyl sulfate or methyl iodide under controlled conditions.

In pharmaceutical applications, 4-(difluoromethoxy)-3-fluorobenzonitrile serves as a key intermediate for synthesizing novel therapeutics. Its structural motif is found in several drug candidates currently undergoing preclinical evaluation for conditions ranging from neurodegenerative diseases to autoimmune disorders. The nitrile group provides a versatile handle for further functionalization, allowing chemists to explore diverse chemical space. For example, hydrolysis of the nitrile group can yield carboxylic acids, which can be further modified into amides or esters—common pharmacophores in drug design.

The agrochemical industry has also recognized the potential of fluorinated benzonitriles as intermediates for developing next-generation pesticides and herbicides. The structural rigidity provided by the aromatic ring combined with electron-withdrawing groups like nitriles enhances binding to biological targets in pests. A recent review article in Pest Management Science highlighted that fluorinated nitriles exhibit improved environmental stability while maintaining high efficacy against resistant strains.

Future research directions for 4-(difluoromethoxy)-3-fluorobenzonitrile may focus on exploring its role in developing antiviral agents targeting RNA viruses. The combination of fluorine and methoxy groups could potentially disrupt viral replication mechanisms by interfering with enzyme-protein interactions or inhibiting capsid assembly. Preliminary data suggest that derivatives of this compound show promise in inhibiting protease enzymes essential for viral maturation.

In conclusion, 4-(difluoromethoxy)-3-fluorobenzonitrile (CAS No. 954388-59-1) is a multifaceted compound with significant potential across multiple sectors of chemical research. Its unique structural features enable diverse applications in pharmaceuticals, agrochemicals, and material science. As synthetic methodologies continue to evolve, new derivatives will likely emerge with enhanced properties suitable for addressing unmet medical needs.

• 331-62-4(3-Fluoro-4-methoxybenzonitrile)
• 1214351-91-3(1-(difluoromethoxy)-2-fluoro-4-methyl-benzene)
• 122008-86-0(3-fluoro-4-(4-hydroxyphenoxy)benzonitrile)
• 243128-37-2(4-Fluoro-3-methoxybenzonitrile)
• 104197-15-1(3,5-Difluoro-4-methoxybenzonitrile)
• 1156079-46-7(4-Ethoxy-3-fluorobenzonitrile)
• 886501-14-0(4-Fluoro-3-(trifluoromethoxy)benzonitrile)
• 1261919-12-3(3-Cyano-5-(3-fluoro-4-methoxyphenyl)phenol)
• 917226-74-5(Benzonitrile, 3-fluoro-4-(2-hydroxyethoxy)-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)